Tag

Advertisement

biotech-1

Martin Åmark

Xbrane announce US FDA filing acceptance

June 27, 2023

The company has announced the …

FDA confirm clinical benefit of BioArctic’s LEQEMBI

June 13, 2023

The FDA Peripheral and Central …

Novo Nordisk invests 15.9 billion DKK in expansion of manufacturing facilities

June 12, 2023

The company will invest 15.9 …

Erik Manting

Mendus enters alliance with NorthX and announces a directed share issue

June 8, 2023

Mendus has entered into a …

Jakob Lindberg

The Swedish Economic Crime Authority terminates investigation of Oncopeptide’s CSO

June 1, 2023

Oncopeptides has been informed that …

Oculis listed on Nasdaq in New York

May 30, 2023

The Iceland-founded biopharmaceutical company was …

Søren Bregenholt

Alligator Bioscience receives FDA Orphan Drug Designation

May 29, 2023

The U.S. Food and Drug …

New Swedish innovation cluster for advanced therapies

May 24, 2023

On behalf of the Swedish …

Gedea Biotech raises 1.3 million EUR

May 24, 2023

The money has been raised …

BioLamina announces release of first batches from new facility

May 23, 2023

BioLamina announces the release of …

Sobi to acquire CTI BioPharma for 1.7 billion USD

May 10, 2023

Swedish Orphan Biovitrum (Sobi) has …

Marc Dunoyer

AstraZeneca’s Koselugo approved in China

May 10, 2023

Koselugo (selumetinib) has been approved …

Johan Liwing

XNK Therapeutics in agreement with global pharma company

May 4, 2023

The company’s autologous natural killer …

Xbrane and STADA supply Ximluci in England

April 26, 2023

The two companies are now …

Martin Åmark

STADA and Xbrane launch ranibizumab in Europe

April 5, 2023

Ranibizumab biosimilar is being launched …

Elypta awarded 1 MUSD Grand Prize from The Roddenberry Foundation

April 5, 2023

The Roddenberry Foundation has announced …

1
2
3
···
9